Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

Ca(2+) modulating α-synuclein membrane transient interactions revealed by solution NMR spectroscopy.

Zhang Z, Dai C, Bai J, Xu G, Liu M, Li C.

Biochim Biophys Acta · 2013-12-04

DOI: 10.1016/j.bbamem.2013.11.016PMID: 24316000

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Dopamine and Cu+/2+ can induce oligomerization of α-synuclein in the absence of oxygen: Two types of oligomerization mechanisms for α-synuclein and related cell toxicity studies.

Ha Y, Yang A, Lee S, Kim K, Liew H, Lee SH, Lee JE, Lee HI, Suh YH, Park HS, Churchill DG.

J Neurosci Res · 2013-11-29

DOI: 10.1002/jnr.23323PMID: 24288134

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Mosaicism of alpha-synuclein gene rearrangements: report of two unrelated cases of early-onset parkinsonism.

Perandones C, Giugni JC, Calvo DS, Raina GB, De Jorge Lopez L, Volpini V, Zabetian CP, Mata IF, Caputo M, Corach D, Radrizzani M, Micheli FE.

Parkinsonism Relat Disord · 2013-11-27

DOI: 10.1016/j.parkreldis.2013.11.014PMID: 24552873

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily.

Stafa K, Tsika E, Moser R, Musso A, Glauser L, Jones A, Biskup S, Xiong Y, Bandopadhyay R, Dawson VL, Dawson TM, Moore DJ.

Hum Mol Genet · 2013-11-26

DOI: 10.1093/hmg/ddt600PMID: 24282027

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

5-S-cysteinyldopamine neurotoxicity: Influence on the expression of α-synuclein and ERp57 in cellular and animal models of Parkinson's disease.

Aureli C, Cassano T, Masci A, Francioso A, Martire S, Cocciolo A, Chichiarelli S, Romano A, Gaetani S, Mancini P, Fontana M, d'Erme M, Mosca L.

J Neurosci Res · 2013-11-22

DOI: 10.1002/jnr.23318PMID: 24273027

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Leucine-rich repeat kinase 2 modulates cyclooxygenase 2 and the inflammatory response in idiopathic and genetic Parkinson's disease.

Lopez de Maturana R, Aguila JC, Sousa A, Vazquez N, Del Rio P, Aiastui A, Gorostidi A, Lopez de Munain A, Sanchez-Pernaute R.

Neurobiol Aging · 2013-11-22

DOI: 10.1016/j.neurobiolaging.2013.11.018PMID: 24360742

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro.

Dulovic M, Jovanovic M, Xilouri M, Stefanis L, Harhaji-Trajkovic L, Kravic-Stevovic T, Kravic-Stevovic T, Paunovic V, Ardah MT, Ardah MT, El-Agnaf OM, Kostic V, Markovic I, Trajkovic V.

Neurobiol Dis · 2013-11-20

DOI: 10.1016/j.nbd.2013.11.002PMID: 24269733

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease.

Mutez E, Nkiliza A, Belarbi K, de Broucker A, Vanbesien-Mailliot C, Bleuse S, Duflot A, Comptdaer T, Semaille P, Blervaque R, Hot D, Leprêtre F, Figeac M, Destée A, Chartier-Harlin MC.

Neurobiol Dis · 2013-11-20

DOI: 10.1016/j.nbd.2013.11.007PMID: 24269915

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Modulation of human α-synuclein aggregation by a combined effect of calcium and dopamine.

Jain MK, Bhat R.

Neurobiol Dis · 2013-11-20

DOI: 10.1016/j.nbd.2013.11.004PMID: 24269918

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein.

Li XZ, Zhang SN, Wang KX, Liu HY, Yang ZM, Liu SM, Lu F.

Phytomedicine · 2013-11-16

DOI: 10.1016/j.phymed.2013.10.012PMID: 24252343

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice.

Martin LJ, Semenkow S, Hanaford A, Wong M.

Neurobiol Aging · 2013-11-16

DOI: 10.1016/j.neurobiolaging.2013.11.008PMID: 24325796

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Over-expression of an inactive mutant cathepsin D increases endogenous alpha-synuclein and cathepsin B activity in SH-SY5Y cells.

Crabtree D, Dodson M, Ouyang X, Boyer-Guittaut M, Liang Q, Ballestas ME, Fineberg N, Zhang J.

J Neurochem · 2013-11-13

DOI: 10.1111/jnc.12497PMID: 24138030

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

9.897 makale bulundu

Ca(2+) modulating α-synuclein membrane transient interactions revealed by solution NMR spectroscopy.

Dopamine and Cu+/2+ can induce oligomerization of α-synuclein in the absence of oxygen: Two types of oligomerization mechanisms for α-synuclein and related cell toxicity studies.

Mosaicism of alpha-synuclein gene rearrangements: report of two unrelated cases of early-onset parkinsonism.

Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily.

5-S-cysteinyldopamine neurotoxicity: Influence on the expression of α-synuclein and ERp57 in cellular and animal models of Parkinson's disease.

Leucine-rich repeat kinase 2 modulates cyclooxygenase 2 and the inflammatory response in idiopathic and genetic Parkinson's disease.

The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro.

Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease.

Modulation of human α-synuclein aggregation by a combined effect of calcium and dopamine.

Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein.

Mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice.

Over-expression of an inactive mutant cathepsin D increases endogenous alpha-synuclein and cathepsin B activity in SH-SY5Y cells.

Filtreler